Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Nordentoft, Merete
2014.
Adolescent cannabis use and adverse sequelae in adulthood.
The Lancet Psychiatry,
Vol. 1,
Issue. 4,
p.
249.
González-Ortega, Itxaso
Alberich, Susana
Echeburúa, Enrique
Aizpuru, Felipe
Millán, Eduardo
Vieta, Eduard
Matute, Carlos
González-Pinto, Ana
and
van Amelsvoort, Therese
2015.
Subclinical Depressive Symptoms and Continued Cannabis Use: Predictors of Negative Outcomes in First Episode Psychosis.
PLOS ONE,
Vol. 10,
Issue. 4,
p.
e0123707.
González-Blanch, César
Gleeson, John F.
Koval, Peter
Cotton, Sue M.
McGorry, Patrick D.
Alvarez-Jimenez, Mario
and
McKenna, Peter John
2015.
Social Functioning Trajectories of Young First-Episode Psychosis Patients with and without Cannabis Misuse: A 30-Month Follow-Up Study.
PLOS ONE,
Vol. 10,
Issue. 4,
p.
e0122404.
DeLisi, Lynn E.
and
Fleischhacker, W. Wolfgang
2015.
The problem of substance abuse in people with schizophrenia.
Current Opinion in Psychiatry,
Vol. 28,
Issue. 3,
p.
199.
Buchy, L.
Cadenhead, K. S.
Cannon, T. D.
Cornblatt, B. A.
McGlashan, T. H.
Perkins, D. O.
Seidman, L. J.
Tsuang, M. T.
Walker, E. F.
Woods, S. W.
Heinssen, R.
Bearden, C. E.
Mathalon, D.
and
Addington, J.
2015.
Substance use in individuals at clinical high risk of psychosis.
Psychological Medicine,
Vol. 45,
Issue. 11,
p.
2275.
Barrowclough, C.
Gregg, L.
Lobban, F.
Bucci, S.
and
Emsley, R.
2015.
The Impact of Cannabis Use on Clinical Outcomes in Recent Onset Psychosis.
Schizophrenia Bulletin,
Vol. 41,
Issue. 2,
p.
382.
van der Meer, F. J.
and
Velthorst, E.
2015.
Course of cannabis use and clinical outcome in patients with non-affective psychosis: a 3-year follow-up study.
Psychological Medicine,
Vol. 45,
Issue. 9,
p.
1977.
Manseau, Marc W.
and
Goff, Donald C.
2015.
Cannabinoids and Schizophrenia: Risks and Therapeutic Potential.
Neurotherapeutics,
Vol. 12,
Issue. 4,
p.
816.
Hsieh, Christina J.
Godwin, Douglass
and
Mamah, Daniel
2016.
Utility of Washington Early Recognition Center Self-Report Screening Questionnaires in the Assessment of Patients with Schizophrenia and Bipolar Disorder.
Frontiers in Psychiatry,
Vol. 7,
Issue. ,
Schoeler, Tabea
Monk, Anna
Sami, Musa B
Klamerus, Ewa
Foglia, Enrico
Brown, Ruth
Camuri, Giulia
Altamura, A Carlo
Murray, Robin
and
Bhattacharyya, Sagnik
2016.
Continued versus discontinued cannabis use in patients with psychosis: a systematic review and meta-analysis.
The Lancet Psychiatry,
Vol. 3,
Issue. 3,
p.
215.
Seddon, Jennifer L.
Birchwood, Max
Copello, Alex
Everard, Linda
Jones, Peter B.
Fowler, David
Amos, Tim
Freemantle, Nick
Sharma, Vimal
Marshall, Max
and
Singh, Swaran P.
2016.
Cannabis Use Is Associated With Increased Psychotic Symptoms and Poorer Psychosocial Functioning in First-Episode Psychosis: A Report From the UK National EDEN Study.
Schizophrenia Bulletin,
Vol. 42,
Issue. 3,
p.
619.
Myles, Hannah
Myles, Nicholas
and
Large, Matthew
2016.
Cannabis use in first episode psychosis: Meta-analysis of prevalence, and the time course of initiation and continued use.
Australian & New Zealand Journal of Psychiatry,
Vol. 50,
Issue. 3,
p.
208.
González-Ortega, Itxaso
Echeburúa, Enrique
García-Alocén, Adriana
Vega, Patricia
and
González-Pinto, Ana
2016.
Cognitive behavioral therapy program for cannabis use cessation in first-episode psychosis patients: study protocol for a randomized controlled trial.
Trials,
Vol. 17,
Issue. 1,
Weibell, Melissa A
Hegelstad, Wenche ten Velden
Auestad, Bjørn
Bramness, Jørgen
Evensen, Julie
Haahr, Ulrik
Joa, Inge
Johannessen, Jan Olav
Larsen, Tor Ketil
Melle, Ingrid
Opjordsmoen, Stein
Rund, Bjørn Rishovd
Simonsen, Erik
Vaglum, Per
McGlashan, Thomas
McGorry, Patrick
and
Friis, Svein
2017.
The Effect of Substance Use on 10-Year Outcome in First-Episode Psychosis.
Schizophrenia Bulletin,
Vol. 43,
Issue. 4,
p.
843.
Conus, Philippe
Cotton, Sue
Schimmelmann, Benno G.
McGorry, Patrick D.
and
Lambert, Martin
2017.
Rates and predictors of 18-months remission in an epidemiological cohort of 661 patients with first-episode psychosis.
Social Psychiatry and Psychiatric Epidemiology,
Vol. 52,
Issue. 9,
p.
1089.
González-Ortega, I.
Martínez-Cengotitabengoa, M.
and
González-Pinto, A.
2017.
Handbook of Cannabis and Related Pathologies.
p.
257.
Rabin, Rachel A.
Kozak, Karolina
Zakzanis, Konstantine K.
Remington, Gary
and
George, Tony P.
2018.
Effects of extended cannabis abstinence on clinical symptoms in cannabis dependent schizophrenia patients versus non-psychiatric controls.
Schizophrenia Research,
Vol. 194,
Issue. ,
p.
55.
Manseau, Marc W.
and
Compton, Michael T.
2018.
The Complex Connection Between Cannabis and Schizophrenia.
p.
1.
Hunt, Glenn E.
Large, Matthew M.
Cleary, Michelle
Lai, Harry Man Xiong
and
Saunders, John B.
2018.
Prevalence of comorbid substance use in schizophrenia spectrum disorders in community and clinical settings, 1990–2017: Systematic review and meta-analysis.
Drug and Alcohol Dependence,
Vol. 191,
Issue. ,
p.
234.
2018.
Adult Psychopathology and Diagnosis, Eighth Edition.
p.
45.